Skip to content

Energy cost of balance control in stroke patients

Energy cost of balance control in stroke patients - Energy cost of balance control

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32235
Enrollment
24
Registered
2008-05-21
Start date
2008-05-25
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CVA Stroke

Interventions

None listed

Sponsors

Vrije Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: *Admitted to rehabilitation centre and diagnosed with stroke *Able to stand without aids or assistance for at least 2 minutes *Maximal score on Berg Balance scale of 45

Exclusion criteria

Exclusion criteria: *Vestibular disease *Cognitive and communicative disorders which could influence the protocol *Medically unstable *Use of medication that could interfere with balance control *Non stroke related sensory or motor impairments that could interfere with balance control

Design outcomes

Primary

MeasureTime frame
Balance *mean amplitude: the average COP distance to the origin of the mean-centered posturogram *sway path length: sum of the distances between consecutive points in the conventional posturogram *the 95% confidence circle area, which represents the area of the posturogram with a circle that includes approximately 95% of the distances from the mean COP (Prieto et al. 1996) *normalized sway path length of the posturogram; measures the amount of twisting and turning *largest Lyapunov exponent; measure for local stability *DFA (detrended fluctuation analysis); determines correlation in time *sample entropy; measure for regularity Energy: *Oxygen consumption in milliliters/ minute/ kilogram *Energy expenditure in Joules/ minute/ kilogram Muscle activity: *root mean square of the EMG data

Secondary

MeasureTime frame
*Berg Balance scale *Medical status of the patient

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)